About Thomas Bliss, Jr.
Form D filings for CyMon Bio in 2024 list Thomas Bliss, Jr. as president and director.
Thomas Bliss, Jr. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Bliss, Jr. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Bliss, Jr. works with at each company, as listed on that company's latest Form D.
CyMon Bio, Inc. · Form D, Feb 12, 2024
KG
Keith Greenfield
Executive officer and director